Solid Biosciences Inc.
SLDB
$6.40
$0.091.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.50% | 7.78% | -30.17% | -30.52% | -3.16% |
| Total Depreciation and Amortization | -5.16% | -16.60% | 20.49% | -67.21% | 277.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.32% | -49.38% | 78.93% | 254.14% | -0.43% |
| Change in Net Operating Assets | -241.61% | -15.78% | -24.93% | 283.76% | 125.89% |
| Cash from Operations | -17.46% | -7.44% | -25.04% | -10.44% | 14.79% |
| Capital Expenditure | -199.21% | 38.24% | -1,260.00% | 94.76% | -91.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.36% | -170.52% | 453.32% | -124.38% | 87.25% |
| Cash from Investing | -19.19% | -171.21% | 451.02% | -112.27% | 86.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.19% | -5.47% | -6.67% | 46.67% | -- |
| Issuance of Common Stock | -99.89% | 2,586.52% | 109.36% | -38.74% | -95.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8,205.00% | -- | -- | 100.00% | 94.07% |
| Cash from Financing | -100.84% | 2,633.83% | 113.14% | -34.88% | -95.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.01% | 722.19% | 150.45% | -45.26% | -149.69% |